Global Laryngeal Cancer Therapeutics Market 2019-2023
About this market
The increasing number of reimbursement programs is one of the key factors expected to boost the laryngeal cancer therapeutics market growth in the forthcoming years. Various governments and vendors are launching patient assistance programs for reducing the high-cost burden associated with the treatment using therapeutics and providing the treatment at an affordable price. As a result, increasing number of patient assistance programs will lead the laryngeal cancer therapeutics market growth during the forecast period. Technavio’s analysts have predicted that the laryngeal cancer therapeutics market will register a CAGR of over 7% by 2023.
A growing number of strategic alliances
The increasing number of strategic alliances among vendors is expected to result in the launch of more advanced therapies and quicker approval. The laryngeal cancer therapeutics market has witnessed strategic alliance for the development of commercialization of drugs for the treatment of laryngeal cancer. This will drive the growth of the market during the forecast period.
Clinical trial failures
The heavy cost involved in recruiting patients for trials and the high cost of the drug cause a significant loss to vendors when a clinical trial fail. Hence, these clinical trial failures are expected to pose a threat to the market growth during the forecast period.
For the detailed list of factors that will drive and challenge the growth of the laryngeal cancer therapeutics market during 2019-2023, view our report.
The market appears to be concentrated with the presence of a few market players. Several organizations are focusing on raising awareness about the head and neck cancer also provides funding for drugs and therapeutics for the treatment and cure of laryngeal cancer. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Technavio Announces the Publication of its Research Report – Global Laryngeal Cancer Therapeutics Market 2019-2023
Technavio recognizes the following companies as the key players in the global laryngeal cancer therapeutics market: Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., and Sanofi.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the last stage pipeline.”
According to the report, one of the major drivers for this market is the growing number of strategic alliances.
Further, the report states that one of the major factors hindering the growth of this market is the clinical trial failures.
Bristol-Myers Squibb Co.Eli Lilly and Co.F. Hoffmann-La Roche Ltd.Merck & Co. Inc.Sanofi
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook